NAD+ IV Therapy
Intravenous nicotinamide adenine dinucleotide infusions for potential anti-aging and cellular rejuvenation
Quick Answer
NAD+ IV therapy delivers nicotinamide adenine dinucleotide directly into the bloodstream, bypassing digestive absorption. NAD+ is essential for cellular energy production and declines with age. Proponents claim IV delivery achieves higher levels than oral supplements. However, human clinical evidence is limited, most NAD+ research uses oral precursors (NR, NMN) in animal models. Side effects during infusion are common (flushing, nausea) but manageable. Typical protocols: 250-500mg infused over 2-4 hours. Cost: $250-1000 per session. Currently an experimental intervention for motivated biohackers.
Emerging
New research, promising but early
Safety: NAD+ IV therapy appears well-tolerated in available research, but human clinical data is limited. Side effects during infusion are common but manageable.
What Is This?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, essential for:
- Energy production: Required for mitochondrial ATP synthesis
- DNA repair: Fuel for PARP enzymes that fix DNA damage
- Sirtuins: NAD+ activates sirtuin proteins linked to longevity
- Cellular signaling: Involved in hundreds of metabolic reactions
- Reduced energy and metabolism
- Impaired DNA repair
- Decreased sirtuin activity
- Mitochondrial dysfunction
NAD+ IV vs. Oral Precursors:
- NAD+ IV: Direct delivery, 2-6 hour infusion, immediate peak levels
- NR (Nicotinamide Riboside): Oral, converts to NAD+ in cells, daily dosing
- NMN (Nicotinamide Mononucleotide): Oral, one step closer to NAD+, daily dosing
How It Works
The theoretical basis for NAD+ therapy rests on aging biology research:
NAD+ and Aging: David Sinclair's lab and others have shown NAD+ decline is a hallmark of aging. Restoring NAD+ in aged mice improves:
- Mitochondrial function
- Insulin sensitivity
- Cardiovascular function
- Cognitive function
- Exercise endurance
DNA Repair: PARP enzymes consume NAD+ to repair DNA damage. Chronic DNA damage (from aging, oxidative stress) depletes NAD+ faster. Replenishing NAD+ may support DNA repair capacity.
Current Evidence: Most evidence comes from:
- Animal studies using oral NR or NMN (positive results)
- Limited human trials with oral precursors (raise blood NAD+, variable clinical outcomes)
- Minimal controlled human data for IV NAD+ specifically
Honest Assessment: NAD+ IV therapy is mechanistically plausible but clinically unproven. We know NAD+ declines with age and replenishing it helps aged animals. We don't yet know if IV NAD+ in humans meaningfully extends healthspan or lifespan.
How to Start
Consider oral precursors first
Before committing to expensive IV therapy, try oral NMN or NR for 1-3 months. These are easier, cheaper, and have more published research. If you see benefits, you may not need IV.
Tips:
- •NMN: 250-500mg daily
- •NR: 300-600mg daily
- •Cost: $30-80/month vs $250-1000 per IV session
- •Most NAD+ research uses oral precursors
Find a reputable provider
NAD+ IV therapy is offered at wellness clinics, functional medicine practices, and longevity centers. Quality varies significantly. Look for medical supervision, pharmaceutical-grade NAD+, and appropriate screening.
Tips:
- •Physician oversight is essential
- •Ask about NAD+ source and purity testing
- •Avoid mobile IV services without proper medical backup
- •Read reviews and ask for credentials
Start with a test dose
First sessions should use lower doses (250mg) to assess tolerance. NAD+ infusions commonly cause flushing, chest tightness, and nausea. Slower infusion rates reduce side effects.
Tips:
- •First session: 250mg over 2-4 hours
- •Side effects are dose- and rate-dependent
- •Eat lightly before infusion
- •Plan 3-6 hours for the full appointment
Assess response and continue if beneficial
Subjectively assess energy, mental clarity, and overall well-being. Protocols vary: some do 3-5 sessions initially then monthly maintenance. Without objective measures, benefits are hard to confirm.
Tips:
- •Keep a symptom journal
- •Benefits may be subtle or placebo
- •Consider NAD+ metabolite testing (limited availability)
- •Combine with lifestyle interventions for synergy
What to Expect
Common side effects
Most people experience some flushing, warmth, chest tightness, or nausea during infusion. These are typically manageable by slowing the infusion rate.
Possible energy boost
Some people report immediate clarity and energy. This may be real or placebo. Effects vary widely between individuals.
Potential sustained benefits
Proponents report improved energy, sleep, and cognition lasting days to weeks after infusion. These are subjective and unconfirmed in controlled trials.
Unknown
Long-term effects of repeated NAD+ IV therapy are unstudied. Theoretical benefits include slowed cellular aging, but this is unproven in humans.
Practical Details
Timing
Infusions typically take 2-6 hours depending on dose and tolerance. Schedule when you can relax afterward. Some people feel energized; others feel tired initially.
Duration
Protocols vary. Common: 3-5 initial sessions over 1-2 weeks, then monthly maintenance. Benefits, if any, appear to require ongoing treatment.
Cost
$250-1000 per session
Initial series of 3-5 sessions costs $1000-5000. Monthly maintenance adds $250-1000/month. Not covered by insurance. Oral precursors (NMN/NR) cost $30-80/month, far cheaper with more research support.
Risks & Considerations
Potential Risks
- •Common infusion side effects (flushing, nausea, chest tightness)
- •IV access complications (bruising, infection, phlebitis)
- •Unknown long-term safety
- •Theoretical cancer concern (NAD+ fuels all rapidly dividing cells)
- •Very expensive for unproven benefits
- •Quality/purity varies between providers
Possible Side Effects
- •Flushing and warmth (very common)
- •Chest tightness (common, usually benign)
- •Nausea (common)
- •Headache (occasional)
- •Fatigue after initial boost (some people)
- •Abdominal cramping (occasional)
Who Should Avoid This
- •Active cancer (theoretical concern, NAD+ may fuel tumor growth)
- •Pregnancy/breastfeeding (no safety data)
- •Severe cardiovascular disease (chest symptoms during infusion)
- •Poor venous access
Key Research
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
Experimental Gerontology, 2020
Systematic review of 147 studies found NAD+ precursors showed favorable outcomes in several age-related disorders but noted limited acute toxicity data and scarcity of long-term human trials.
View StudyClinical Evidence for Targeting NAD Therapeutically
Pharmaceuticals, 2020
Review noting NAD pharmacology is a promising class of treatments with likely favorable side effect profile, but only a small number of randomized, adequately powered clinical trials have been conducted.
View StudyThe Role of NAD+ in Regenerative Medicine
Regenerative Medicine, 2022
Review examining NAD+ role in tissue regeneration, noting therapeutic potential but emphasizing need for more human clinical data.
View StudyFrequently Asked Questions
Is NAD+ IV better than oral supplements?
Unclear. IV bypasses digestive degradation but it's uncertain whether IV NAD+ enters cells more effectively than oral precursors (NMN, NR) that are converted to NAD+ inside cells. Most published research uses oral precursors. IV is much more expensive and time-consuming.
Why does NAD+ IV cause side effects?
NAD+ infusion causes histamine release and vasodilation, producing flushing, warmth, and chest tightness. These are typically not dangerous but uncomfortable. Slowing the infusion rate reduces symptoms. Starting with lower doses helps assess tolerance.
How long do benefits last?
Subjectively reported benefits (energy, clarity) may last days to weeks. NAD+ levels return to baseline relatively quickly after a single infusion, which is why maintenance protocols involve repeated sessions.
Can NAD+ therapy cause cancer?
This is a theoretical concern. NAD+ is essential for all cells, including cancer cells. Raising NAD+ might fuel tumor growth. However, NAD+ also supports DNA repair which prevents cancer. The net effect is unknown. Those with active cancer should avoid NAD+ therapy.
What's a typical protocol?
Common protocols: 3-5 infusions of 250-500mg over 1-2 weeks (loading phase), then monthly maintenance infusions. Some clinics offer higher doses (1000mg+). There's no established optimal protocol, this is experimental medicine.
Sources
Related Interventions
Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any new health practice or supplement. Evidence levels and recommendations can change, this content was last updated December 2025.